Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5513 | 2021 |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2106* | 2021 |
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans R Wilson, R Ainscough, K Anderson, C Baynes, M Berks, J Bonfield, ... Nature 368 (6466), 32-38, 1994 | 1843 | 1994 |
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1381 | 2021 |
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... The Lancet 395 (10241), 1919-1926, 2020 | 1236 | 2020 |
Lectures on rhetoric and belles lettres A Smith | 1069 | 1985 |
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 752 | 2021 |
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 647 | 2020 |
A high‐resolution global flood hazard model CC Sampson, AM Smith, PD Bates, JC Neal, L Alfieri, JE Freer Water resources research 51 (9), 7358-7381, 2015 | 524 | 2015 |
An Inquiry in to the Nature and Causes of the Wealth of Nations A Smith Encyclopaedia Britannica, 1990 | 399 | 1990 |
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 340 | 2022 |
Approaches to studying racism and sexism in Black women's lives. A Smith, AJ Stewart Journal of Social issues 39 (3), 1983 | 333 | 1983 |
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 326* | 2022 |
The Dragonfly Effect: Quick, effective, and powerful ways to use social media to drive social change J Aaker Jossey Bass, 2010 | 319 | 2010 |
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. AB Price, J Levi, JM Dolby, PL Dunscombe, A Smith, J Clark, ... Gut 26 (11), 1183-1188, 1985 | 318 | 1985 |
Validation of a 30 m resolution flood hazard model of the conterminous U nited S tates OEJ Wing, PD Bates, CC Sampson, AM Smith, KA Johnson, TA Erickson Water Resources Research 53 (9), 7968-7986, 2017 | 306 | 2017 |
The conjugate addition of enantiomerically pure lithium amides as homochiral ammonia equivalents: scope, limitations and synthetic applications SG Davies, AD Smith, PD Price Tetrahedron: Asymmetry 16 (17), 2833-2891, 2005 | 296 | 2005 |
Organocatalytic functionalization of carboxylic acids: isothiourea-catalyzed asymmetric intra-and intermolecular michael addition− lactonizations D Belmessieri, LC Morrill, C Simal, AMZ Slawin, AD Smith Journal of the American Chemical Society 133 (8), 2714-2720, 2011 | 294 | 2011 |
NHCs in asymmetric organocatalysis: recent advances in azolium enolate generation and reactivity J Douglas, G Churchill, AD Smith Synthesis 44 (15), 2295-2309, 2012 | 292 | 2012 |
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 290 | 2019 |